Ceelen, Liesbeth PhD; De Zwart, Loeckie PhD; Voets, Marieke PhD; Hillewaert, Vera MSc; Monbaliu, Johan PhD; Teuns, Greet DVM; Coussement, Werner PhD; Greway, Tony PhD
Author Information
From the *Department of Toxicology, Dermato-Cosmetology and Pharmacognosy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels; †Johnson & Johnson Pharmaceutical Research and Development, Janssen Pharmaceutica, Global Preclinical Development Beerse Site, Beerse, Belgium; and ‡Johnson & Johnson Pharmaceutical Research and Development, LLC, Raritan, NJ.
Manuscript received August 4, 2010; accepted August 23, 2010.
The authors report no conflicts of interest.
Reprints: Liesbeth Ceelen, PhD, Department of Toxicology, Dermato-Cosmetology and Pharmacognosy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium. E-mail: [email protected].
doi: 10.1097/PAF.0b013e3181fbbb49